Intestinal tumor load in the MIN/+ mouse model is not correlated with eicosanoid biosynthesis

Advances in Experimental Medicine and Biology

Volumn 469, Issue , 2000, Pages 607-615

  Whelan, J ^a   Chiu, C H ^a   McEntee, M F ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; INDOMETACIN; PROSTAGLANDIN E2; SULINDAC;

ANIMAL MODEL; ANIMAL TISSUE; BIOSYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; INTESTINE TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; ASPIRIN; DINOPROSTONE; EICOSANOIDS; GENES, APC; INDOMETHACIN; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; SULINDAC;

ANIMALIA;

EID: 0034465706     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (43)

1. Aspirin use, cancer, and polyps of the large bowel
2. Low-dose aspirin and incidence of colorectal tumors in a randomized trial
3. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer
4. Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas
5. Prostaglandin endoperoxide synthase: Why two isoforms?
6. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
7. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
8. The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system
9. Inactivation of both APC alleles in human and mouse tumors
10. Loss of Apc+ in intestinal adenomas from Min mice
11. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients
12. Identification of FAP locus genes from chromosome 5q21
13. Identification and characterization of the familial adenomatous polyposis coli gene
14. APC mutations occur early during colorectal tumorigenesis
15. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
16. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
17. Sulindac for polyposis of the colon
18. Sulindac therapy of colorectal polyps in familial adenomatous polyposis
19. Cyclooxygenase-2 overexpression and tumor formation are blocked by Sulindac in a murine model of familial adenomatous polyposis
20. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
21. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
22. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
23. Dietary arachidonate enhances tissue arachidonate levels and eicosanoid production in syrian hamsters
24. Protein determination in membrane and lipoprotein samples: Manual and automated procedures
25. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
26. A protective effect of sulindac against chemically-induced primary colonic tumours in mice
27. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme
28. Effect of piroxicam on primary intestinal tumors reduced in rats by N-methylnitrosourea
29. Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo
30. The effect of linoleic, arachidonic and eicosapentaenoic acid supplementation on prostacyclin production in rats
31. Increased dietary arachidonic acid enhances the synthesis of vasoactive eicosanoids in humans
32. Sulindac suppresses tumorigenesis in the Min mouse
33. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
34. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
35. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
36. The disposition of sulindac
37. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
38. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs
39. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs
40. Suppression of intestinal polyp development by nimesulide, a selective cylooxygenase-2 inhibitor, in Min mice
41. Elevated cyclooxygenase-2 levels in Min mouse adenomas
42. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
43. Expression of cyclooxygenase-1 and -2 in human colorectal cancer